STOCK TITAN

[EFFECT] Silexion Therapeutics Corp SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: May 11, 2026
Accession Number: 0001178913-26-002444
Submission Type: POS AM
CIK: 0002022416
Company Name: Silexion Therapeutics Corp
File Number: 333-290074